Diseases & Disorders
(G53Z)
IRS Verified
DX Registered
990 on File
MULTIPLE SCLEROSIS SOCIETY OF PORTLAND OREGON INC
Financial strength (30%)
23/100
Reliability (20%)
55/100
Effectiveness (25%)
31/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$50K
Total Revenue
$226K
Total Expenses
$-3,486
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
5.3%
Fundraising Efficiency
72.2%
Operating Reserve
-0.19x
Liability-to-Asset
115.6%
Revenue Diversification
22.5%
Compared with Peers
FY 2024
Compared with 1,546 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
5.3% | 83.1% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
72.2% | 19.5% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
-0.2 mo | 12.0 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
115.6% | 0.7% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
22.5% | 93.9% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-35.3% | 7.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
44.7% | 9.2% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-347.6% | 1.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $50K | $226K | $-3,486 | 5.3% | — |
| 2023 | $78K | $156K | $172K | 29.7% | — |
| 2022 | $159K | $234K | $248K | 46.4% | — |
| 2021 | $485K | $381K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.